Protiere, C.; Fressard, L.; Mora, M.; Meyer, L.; Préau, M.; Suzan-Monti, M.; Lelièvre, J.-D.; Lambotte, O.; Spire, B.; the APSEC Study Group.
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study. Vaccines 2020, 8, 334.
https://doi.org/10.3390/vaccines8020334
AMA Style
Protiere C, Fressard L, Mora M, Meyer L, Préau M, Suzan-Monti M, Lelièvre J-D, Lambotte O, Spire B, the APSEC Study Group.
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study. Vaccines. 2020; 8(2):334.
https://doi.org/10.3390/vaccines8020334
Chicago/Turabian Style
Protiere, Christel, Lisa Fressard, Marion Mora, Laurence Meyer, Marie Préau, Marie Suzan-Monti, Jean-Daniel Lelièvre, Olivier Lambotte, Bruno Spire, and the APSEC Study Group.
2020. "Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study" Vaccines 8, no. 2: 334.
https://doi.org/10.3390/vaccines8020334
APA Style
Protiere, C., Fressard, L., Mora, M., Meyer, L., Préau, M., Suzan-Monti, M., Lelièvre, J. -D., Lambotte, O., Spire, B., & the APSEC Study Group.
(2020). Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study. Vaccines, 8(2), 334.
https://doi.org/10.3390/vaccines8020334